To the full analysis
Buyback calculator for Phibro Animal Health
Phibro Animal Health stock: key metrics
PAHCPhibro Animal Health had an operating margin of 13.1% and a return on invested capital (ROIC) of 14% in fiscal 2026.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2007 | 24.5% | 4.7% | −1.5% |
| 2008 | 23.8% | 5.7% | 0.4% |
| 2009 | 24.1% | 7.7% | −1.5% |
| 2010 | 26.0% | 8.9% | 7.1% |
| 2011 | 23.7% | 6.7% | −2.1% |
| 2012 | 25.1% | 7.5% | 1.1% |
| 2013 | 27.4% | 8.7% | 3.8% |
| 2014 | 30.0% | 9.2% | −0.4% |
| 2015 | 31.6% | 11.7% | 8.1% |
| 2016 | 31.8% | 11.4% | 11.0% |
| 2017 | 32.5% | 12.8% | 8.5% |
| 2018 | 32.5% | 12.1% | 7.9% |
| 2019 | 32.0% | 8.9% | 6.6% |
| 2020 | 32.1% | 8.6% | 4.2% |
| 2021 | 32.6% | 9.0% | 6.5% |
| 2022 | 30.3% | 8.4% | 5.2% |
| 2023 | 30.5% | 7.3% | 3.3% |
| 2024 | 30.8% | 5.2% | 0.2% |
| 2025 | 30.9% | 8.5% | 3.7% |
| 2026 | 33.7% | 13.1% | 6.6% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2007 | 7.6% | 12.5% | −2.5% |
| 2008 | 0.0% | 10.4% | 0.0% |
| 2009 | 0.0% | no data | 0.0% |
| 2010 | 0.0% | no data | 0.0% |
| 2011 | 0.0% | no data | 0.0% |
| 2012 | −7.9% | 12.6% | 1.6% |
| 2013 | −36.1% | 23.8% | 5.2% |
| 2014 | −20.5% | 11.4% | −0.7% |
| 2015 | 200.0% | 23.0% | 12.2% |
| 2016 | 91.4% | 24.5% | 13.5% |
| 2017 | 42.7% | 19.2% | 10.4% |
| 2018 | 35.1% | 17.6% | 9.7% |
| 2019 | 25.3% | 12.8% | 7.5% |
| 2020 | 17.8% | 8.6% | 4.3% |
| 2021 | 22.8% | 11.3% | 6.5% |
| 2022 | 18.7% | 8.8% | 5.3% |
| 2023 | 11.5% | 6.4% | 3.4% |
| 2024 | 0.9% | 3.9% | 0.2% |
| 2025 | 16.9% | 9.6% | 3.5% |
| 2026 | 25.9% | 14.0% | 6.6% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 30 Jun 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 6 Mar 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.